LIPERTANCE 10mg / 5mg / 5mg tablets medication leaflet

C10BX11 • atorvastatin + perindopril + amlodipine • Cardiovascular system | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

The combination of atorvastatin, perindopril, and amlodipine is used for the treatment of patients at high cardiovascular risk who require simultaneous management of dyslipidemia, hypertension, and other cardiovascular risk factors. Atorvastatin lowers LDL cholesterol levels, perindopril is an angiotensin-converting enzyme (ACE) inhibitor that reduces blood pressure and protects the heart, and amlodipine is a calcium channel blocker that relaxes blood vessels.

This combination is administered orally, usually once daily, with the dosage adjusted based on the patient's needs and response to treatment. It is particularly indicated for patients with stable cardiovascular disease or multiple comorbidities.

Common side effects include dizziness, headaches, peripheral edema, dry cough, and muscle pain. In rare cases, severe adverse reactions such as renal failure, rhabdomyolysis, or allergic reactions may occur.

Patients taking this combination should undergo regular monitoring for liver and kidney function, lipid levels, and blood pressure. The atorvastatin, perindopril, and amlodipine combination provides a comprehensive solution for managing overall cardiovascular risk, helping to prevent major cardiovascular events.